Astec Lifesciences (NSE:ASTEC) Marketable Securities: ₹5 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:ASTEC Astec Lifesciences Ltd NSE:ASTEC
76 GF Score
Price ₹690.75
GF Value ₹993.59
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is Astec Lifesciences Marketable Securities?

Astec Lifesciences NSE:ASTEC -1.38% 76 Marketable Securities is ₹5 Mil as of Mar. 2026. GuruFocus rates NSE:ASTEC with a GF Score™ of 76/100 and a GF Value™ of ₹993.59 (Significantly Undervalued). The stock has 4 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Astec Lifesciences's Marketable Securities for the quarter that ended in Mar. 2026 was ₹5 Mil.

Astec Lifesciences's annual Marketable Securities declined from Mar. 2024 (₹12 Mil) to Mar. 2025 (₹3 Mil) but then increased from Mar. 2025 (₹3 Mil) to Mar. 2026 (₹5 Mil).

Astec Lifesciences  (NSE:ASTEC) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Astec Lifesciences Marketable Securities Related Terms

Astec Lifesciences Marketable Securities Historical Data

* Premium members only.

The historical data trend for Astec Lifesciences's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Astec Lifesciences Marketable Securities Chart

Astec Lifesciences Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 27.90 2.47 11.76 2.80 4.87

Astec Lifesciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.80 0.00 74.73 0.00 4.87
NSE:ASTEC
76GF Score
Astec Lifesciences Ltd NSE:ASTEC
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Astec Lifesciences Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of ₹5 Mil mean?
Astec Lifesciences (NSE:ASTEC) has a Marketable Securities of ₹5 Mil as of Mar. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Astec Lifesciences and its competitors.
Is Astec Lifesciences' Marketable Securities too high?
Astec Lifesciences' current Marketable Securities is ₹5 Mil. Overall, Astec Lifesciences has a GF Score™ of 76/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Astec Lifesciences' Marketable Securities compare to CTVA and CF?
Astec Lifesciences' Marketable Securities of ₹5 Mil can be compared against companies in the Agriculture industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for an Agriculture company?
A good Marketable Securities depends on the Agriculture industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Astec Lifesciences and its competitors. Astec Lifesciences's current Marketable Securities is ₹5 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Astec Lifesciences stock overvalued right now?
Based on GuruFocus' analysis, Astec Lifesciences (NSE:ASTEC) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹993.59, compared to a current price of ₹690.75 — trading 30.5% below its estimated fair value. The current Marketable Securities is ₹5 Mil. Astec Lifesciences' overall GF Score™ is 76/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Astec Lifesciences (NSE:ASTEC), the current Marketable Securities is ₹5 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Astec Lifesciences (NSE:ASTEC) Overvalued in 2026?

Based on GuruFocus' analysis, Astec Lifesciences stock appears to be undervalued. The current stock price of ₹690.75 is trading 30.5% below its estimated GF Value™ of ₹993.59. GuruFocus considers Astec Lifesciences to be Significantly Undervalued.

Key valuation signals for NSE:ASTEC:

  • Marketable Securities: ₹5 Mil
  • GF Value™: ₹993.59 vs. price of ₹690.75 (30.5% below fair value)
  • GF Score™: 76/100 with 4 warning signs

No single metric tells the full story. See the NSE:ASTEC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Astec Lifesciences Business Description

Other Exchanges 533138:India
Address Eastern Express Highway, Godrej One, 3rd Floor, Pirojshanagar, Vikhroli (East), Mumbai, MH, IND, 400 079
Astec Lifesciences Ltd manufactures & distributes a wide range of Agrochemical active ingredients and pharmaceutical intermediates. The company's products include agrochemicals, such as Triazole Fungicides, Herbicides, and Insecticides. The company is also into Intermediates & Specialty chemicals. Geographically, all the operations of the firm function through India; however, its products are sold in the Indian and overseas markets. It operates in the business segment of Agrochemicals and has a business presence in India and outside India.
76GF Score

Get the complete analysis for NSE:ASTEC

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹690.75
Price
₹993.59
GF Value